tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Driscoll, 194 are a BUY (88.58%), 24 are a HOLD (10.96%), 1 are a SELL (0.46%).
Analyst Robert Driscoll, currently employed at WEDBUSH, carries an average stock price target met ratio of 42.66% that have a potential upside of 65.84% achieved within 164 days.
Robert Driscoll’s has documented 430 price targets and ratings displayed on 34 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IDYA, Ideaya Biosciences at 17-Dec-2024.
Analyst best performing recommendations are on ABUS (ARBUTUS BIOPHARMA CORP).
The best stock recommendation documented was for ABUS (ARBUTUS BIOPHARMA CORP) at 10/9/2018. The price target of $5 was fulfilled within 1 day with a profit of $1 (16.67%) receiving and performance score of 166.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$1.67 (50.15%)
$5
16 days ago
(21-Jan-2025)
0/17 (0%)
$1.79 (55.76%)
Buy
$5
$1.67 (50.15%)
$4
2 months 17 days ago
(20-Nov-2024)
4/11 (36.36%)
$1.51 (43.27%)
136
Buy
$5
$1.67 (50.15%)
$4
6 months 4 days ago
(02-Aug-2024)
2/6 (33.33%)
$1.26 (33.69%)
256
Buy
$5
$2.08 (71.23%)
3 years 4 days ago
(02-Feb-2022)
0/1 (0%)
$2.11 (73.01%)
Buy
$7
3 years 7 months 9 days ago
(28-Jun-2021)
0/4 (0%)
$3.7 (112.12%)
Which stock is Robert Driscoll is most bullish on?
Which stock is Robert Driscoll is most reserved on?
What Year was the first public recommendation made by Robert Driscoll?
